TY - JOUR
T1 - Outcomes of Venous Malformation Sclerotherapy
T2 - A Review of Study Methodology and Long-Term Results
AU - Ali, Sumera
AU - Mitchell, Sally E.
N1 - Publisher Copyright:
© 2017 by Thieme Medical Publishers, Inc.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - It is very important that patients seeking sclerotherapy for the treatment of venous malformations are aware of the expected course of the therapy. They should be thoroughly counseled about the complications, the need for multiple sessions of therapy, and also about the expected clinical outcome. The aim of this review is to discuss the long-term outcomes of sclerotherapy for the treatment of venous malformation. Many studies have discussed their individual center's experiences and short-midterm results, but there is a relative paucity of data on long-term outcomes. We have reviewed the literature and also shared our experience of a large cohort of patients (n = 116) with a relatively longer follow-up period of more than 1 year. Venous malformations are very complex lesions and their treatment is quite variable depending on its extent and complexity. As a result, outcome studies vary considerably in the choice of sclerosant, study methodology, outcome assessment (clinical vs. imaging), and grading scales. This review also highlights this extreme heterogeneity in the literature of the sclerotherapy outcome and summarizes a few national and international studies for comparison.
AB - It is very important that patients seeking sclerotherapy for the treatment of venous malformations are aware of the expected course of the therapy. They should be thoroughly counseled about the complications, the need for multiple sessions of therapy, and also about the expected clinical outcome. The aim of this review is to discuss the long-term outcomes of sclerotherapy for the treatment of venous malformation. Many studies have discussed their individual center's experiences and short-midterm results, but there is a relative paucity of data on long-term outcomes. We have reviewed the literature and also shared our experience of a large cohort of patients (n = 116) with a relatively longer follow-up period of more than 1 year. Venous malformations are very complex lesions and their treatment is quite variable depending on its extent and complexity. As a result, outcome studies vary considerably in the choice of sclerosant, study methodology, outcome assessment (clinical vs. imaging), and grading scales. This review also highlights this extreme heterogeneity in the literature of the sclerotherapy outcome and summarizes a few national and international studies for comparison.
KW - interventional radiology
KW - sclerotherapy
KW - venous malformation
UR - http://www.scopus.com/inward/record.url?scp=85033692429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033692429&partnerID=8YFLogxK
U2 - 10.1055/s-0037-1604300
DO - 10.1055/s-0037-1604300
M3 - Review article
C2 - 28955118
AN - SCOPUS:85033692429
SN - 0739-9529
VL - 34
SP - 288
EP - 293
JO - Seminars in Interventional Radiology
JF - Seminars in Interventional Radiology
IS - 3
ER -